New technology for non-invasive treatment of Alzheimer's disease
Circulatronics: A New Paradigm for Biomedical Implants
This study is exploring a new technology called 'Circulatronics' that uses tiny devices to help detect and treat Alzheimer's disease without surgery, aiming to improve care by targeting the brain early on.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10938896 on NIH RePORTER |
What this research studies
This research focuses on developing a groundbreaking technology called 'Circulatronics' that utilizes ultra-small bioelectronic devices to target specific areas in the body for sensing and treatment without the need for invasive surgery. By leveraging advanced nanoelectronics and novel materials, the project aims to create tiny devices that can precisely deliver therapies to regions affected by Alzheimer's disease. This approach seeks to address the limitations of current Alzheimer's treatments, which often only provide minimal symptomatic relief. The technology aims to intervene early in the disease process, targeting pathological changes in the brain associated with Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage Alzheimer's disease or those at risk of developing the condition.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and less invasive treatments for Alzheimer's disease, potentially improving patient outcomes significantly.
How similar studies have performed: While the concept of using bioelectronic devices for treatment is emerging, this specific approach is novel and has not been extensively tested in the context of Alzheimer's disease.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Sarkar, Deblina — Massachusetts Institute of Technology
- Study coordinator: Sarkar, Deblina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.